Virginia Retirement Systems’s Corcept Therapeutics CORT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.31M | Buy |
26,574
+16,000
| +151% | +$966K | 0.01% | 507 |
|
|
2026
Q1 | $426K | Sell |
10,574
-800
| -7% | -$29.9K | ﹤0.01% | 795 |
|
|
2025
Q4 | $396K | Sell |
11,374
-4,800
| -30% | -$377K | ﹤0.01% | 800 |
|
|
2025
Q3 | $1.34M | Sell |
16,174
-400
| -2% | -$28.9K | 0.01% | 505 |
|
|
2025
Q2 | $1.22M | Sell |
16,574
-100
| -0.6% | -$7.25K | 0.01% | 531 |
|
|
2025
Q1 | $1.9M | Buy |
+16,674
| New | +$1.01M | 0.01% | 381 |
|
|
2023
Q3 | $1.61M | Sell |
59,000
-5,200
| -8% | -$150K | 0.02% | 386 |
|
|
2023
Q2 | $1.43M | Sell |
64,200
-900
| -1% | -$20.7K | 0.01% | 443 |
|
|
2023
Q1 | $1.41M | Buy |
65,100
+16,600
| +34% | +$364K | 0.01% | 441 |
|
|
2022
Q4 | $985K | Buy |
48,500
+4,100
| +9% | +$103K | 0.01% | 611 |
|
|
2022
Q3 | $1.14M | Buy |
+44,400
| New | +$1.19M | 0.01% | 532 |
|
|
2022
Q1 | $1.37M | Sell |
60,700
-7,500
| -11% | -$160K | 0.01% | 539 |
|
|
2021
Q4 | $1.35M | Sell |
68,200
-1,100
| -2% | -$22.3K | 0.01% | 552 |
|
|
2021
Q3 | $1.36M | Buy |
69,300
+18,800
| +37% | +$393K | 0.01% | 529 |
|
|
2021
Q2 | $1.11M | Buy |
50,500
+2,200
| +5% | +$49K | 0.01% | 610 |
|
|
2021
Q1 | $1.15M | Buy |
48,300
+6,200
| +15% | +$166K | 0.01% | 604 |
|
|
2020
Q4 | $1.1M | Sell |
42,100
-7,600
| -15% | -$160K | 0.01% | 573 |
|
|
2020
Q3 | $865K | Sell |
49,700
-19,300
| -28% | -$308K | 0.01% | 582 |
|
|
2020
Q2 | $1.16M | Sell |
69,000
-11,500
| -14% | -$162K | 0.01% | 515 |
|
|
2020
Q1 | $957K | Buy |
80,500
+8,000
| +11% | +$99K | 0.01% | 572 |
|
|
2019
Q4 | $877K | Sell |
72,500
-20,000
| -22% | -$278K | 0.01% | 742 |
|
|
2019
Q3 | $1.31M | Sell |
92,500
-8,700
| -9% | -$107K | 0.01% | 580 |
|
|
2019
Q2 | $1.13M | Sell |
101,200
-19,700
| -16% | -$220K | 0.01% | 634 |
|
|
2019
Q1 | $1.42M | Buy |
120,900
+48,300
| +67% | +$600K | 0.02% | 536 |
|
|
2018
Q4 | $970K | Buy |
72,600
+58,800
| +426% | +$777K | 0.01% | 629 |
|
|
2018
Q3 | $193K | Sell |
13,800
-63,900
| -82% | -$893K | ﹤0.01% | 1020 |
|
|
2018
Q2 | $1.22M | Sell |
77,700
-6,500
| -8% | -$113K | 0.02% | 624 |
|
|
2018
Q1 | $1.39M | Sell |
84,200
-12,300
| -13% | -$228K | 0.02% | 555 |
|
|
2017
Q4 | $1.74M | Sell |
96,500
-12,000
| -11% | -$217K | 0.02% | 516 |
|
|
2017
Q3 | $2.09M | Buy |
108,500
+97,700
| +905% | +$1.46M | 0.03% | 486 |
|
|
2017
Q2 | $127K | Buy |
+10,800
| New | +$117K | ﹤0.01% | 1024 |
|
Other funds holding CORT
ISL
PA
Virginia Retirement Systems's CORT Position: Q2 2026 in Review
Virginia Retirement Systems increased its Corcept Therapeutics (CORT) stake by 151% in Q2 2026, buying an estimated $966K and bringing the position to 26,574 shares worth $2.31M. The position accounts for 0.01% of the portfolio, ranked #507.
Virginia Retirement Systems first reported a position in CORT in Q2 2017 and has held it in 31 quarters since. 423 funds tracked by Wall St. Rank hold CORT as of Q2 2026.
- Virginia Retirement Systems held 26,574 shares of Corcept Therapeutics worth $2.31M as of Q2 2026.
- Virginia Retirement Systems bought 16,000 Corcept Therapeutics shares in Q2 2026, an estimated $966K.
- Corcept Therapeutics made up 0.01% of Virginia Retirement Systems's portfolio in Q2 2026, its #507 holding.
- Virginia Retirement Systems first reported a position in Corcept Therapeutics in Q2 2017 and has held it in 31 quarters since.
- 423 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q2 2026.
Based on Virginia Retirement Systems's 13F filing for Q2 2026, filed 25 Aug 2026.